Document Detail

Pharmacy benefit management: enhancing the applicability of pharmacoeconomics for optimal decision making.
MedLine Citation:
PMID:  11817989     Owner:  NLM     Status:  MEDLINE    
Previous research indicates that in order to make pharmacoeconomic information applicable and useful for pharmaceutical benefit management (PBM) companies, several aspects need to be considered and improved. These include: timely availability of information, head-to-head comparators, peer-reviewed publications, independent sponsorship of pharmacoeconomic studies, use of relevant populations in research and published pharmacoeconomic models, and pharmacoeconomics training for pharmaceutical companies' sales personnel. In addition to these measures, guidelines have been playing an important role in improving the applicability of pharmacoeconomic information. This paper examines the progress to date in enhancing the applicability of pharmacoeconomics for optimal PBM decision making. The greatest improvements have been made in enhancing the quality of pharmacoeconomic research and the quality of peer-reviewed publications. Direct comparator studies are starting to emerge, but in limited numbers. The need for additional training of pharmaceutical representatives and PBM staff members remains a critical issue.
C Daniel Mullins; Junling Wang
Related Documents :
15801869 - Lasofoxifene: cp 336156, cp-336156.
24421049 - Specialized science.
24806729 - Is the aluminum hypothesis dead?
23624789 - Quantitative microscopy of the lung - a problem-based approach part 1: basic principles...
7772289 - Forty years of screening programmes for antibiotics.
23294089 - Pretense and possibility-a theoretical proposal about the effects of pretend play on de...
10102509 - A triad of research roles: experiential learning in an undergraduate research course.
11827089 - Analogical problem solving: a hierarchical analysis of procedural similarity.
7660659 - The role of the lay midwife in childbirth in rural portugal.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  PharmacoEconomics     Volume:  20     ISSN:  1170-7690     ISO Abbreviation:  Pharmacoeconomics     Publication Date:  2002  
Date Detail:
Created Date:  2002-01-30     Completed Date:  2002-05-24     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  9212404     Medline TA:  Pharmacoeconomics     Country:  New Zealand    
Other Details:
Languages:  eng     Pagination:  9-21     Citation Subset:  T    
School of Pharmacy, Center on Drugs and Public Policy, University of Maryland, Baltimore, Maryland, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cost-Benefit Analysis
Decision Making*
Disease Management
Drug Evaluation / economics
Drug Information Services / standards*,  supply & distribution
Drug Utilization Review
Drugs, Generic
Economics, Pharmaceutical*
Formularies as Topic
Health Care Sector
Insurance, Pharmaceutical Services / utilization*
Managed Care Programs / standards
Peer Review, Research
Pharmaceutical Services / economics*
Pharmacy and Therapeutics Committee
Practice Guidelines as Topic
Treatment Outcome
United States
Reg. No./Substance:
0/Drugs, Generic

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Economic evaluation of vaccination programmes: a consensus statement focusing on viral hepatitis.
Next Document:  Onychomycosis: health-related quality of life considerations.